Current prospects of fluoroquinolones: pazufloxacin. A review

Current prospects of fluoroquinolones: pazufloxacin. A review

Fluoroquinolones (FQ) are one of the most valuable groups of antibacterial drugs in clinical practice. Ciprofloxacin and levofloxacin are drugs with the largest contribution to the structure of FQ consumption both in the Russian Federation and in the world. The widespread use of FQ in recent years h...

Full description

Saved in:

Bibliographic Details
Main Authors:	Olga I. Butranova, Sergey K. Zyryanov, Anna R. Melnikova, Anastasia E. Matsepuro
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2025-01-01
Series:	Терапевтический архив
Subjects:	fluoroquinolones pazufloxacin antibiotic resistance infectious diseases
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/680092/202486
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fluoroquinolones and Biofilm: A Narrative Review
by: Nicholas Geremia, et al.
Published: (2024-12-01)

The diverse phenotypic and mutational landscape induced by fluoroquinolone treatment
by: Sayed Golam Mohiuddin, et al.
Published: (2025-08-01)

Emerging fluoroquinolone and ketolide resistance in Haemophilus parainfluenzae in South Africa
by: Regina Esinam Abotsi, et al.
Published: (2017-04-01)

Emerging Enterococcus isolates in postoperative endophthalmitis by selection pressure of fluoroquinolones: an 11-year multicenter and experimental study
by: Jiyeun Kate Kim, et al.
Published: (2020-01-01)

Impact of fluoroquinolone and heavy metal pollution on antibiotic resistance maintenance in aquatic ecosystems
by: Emilie Dehon, et al.
Published: (2025-05-01)

Fluoroquinolone-specific resistance trajectories in E. coli and their dependence on the SOS-response
by: Lisa Teichmann, et al.
Published: (2025-01-01)

DRUG UTILIZATION REVIEW OF FLUOROQUINOLONES ANTIBIOTICS BY USING PRESCRIBING INDICATORS & COMPARISON OF DEFINE DAILY DOSE & PRESCRIBED DAILY DOSE IN OUTPATIENTS
Published: (2021-04-01)

Francisella tularensis: FupA mutation contributes to fluoroquinolone resistance by increasing vesicle secretion and biofilm formation
by: Claire Siebert, et al.
Published: (2019-01-01)

Optimization, characterization, and DFT study of activated-biochar from lignocellulosic biomass for fluoroquinolone antibiotic adsorption
by: Kawtar Ezzahi, et al.
Published: (2025-09-01)

Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management
by: Samer Wahood, et al.
Published: (2025-05-01)

Side effects of fluoroquinolone antibiotics: dysglycemia and psychical disorders
by: A. V. Kuzmina, et al.
Published: (2021-06-01)

Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?
by: Adalet Altunsoy, et al.
Published: (2024-04-01)

Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study
by: Alshareef H, et al.
Published: (2025-02-01)

Effect of Perioperative Antibacterial Prophylaxis Using Eye Drops with Fluoroquinolones on Conjunctival Microflora in Patients before and after Phacoemulsification
by: Yu. I. Pirogov, et al.
Published: (2020-04-01)

Cardiac toxicity of fluoroquinolones and bedaquiline
by: G. N. Mozhokinа, et al.
Published: (2019-05-01)

Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with SalmonellaTyphi?
by: Seema Irfan, et al.
Published: (2012-10-01)

FACTORS ASSOCIATED WITH ACQUIRED FLUOROQUINOLONE RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS IN THE NOVOSIBIRSK REGION
by: Ya. R. Batyrshina, et al.
Published: (2014-05-01)

Antibiotic resistance profiles of Campylobacter species in the South Africa private health care sector
by: Christiana O. Shobo, et al.
Published: (2016-11-01)

Veterinary fluoroquinolones as emerging contaminants in marine environments: In vitro study of biochemical responses in subcellular fractions of the Mediterranean mussel (Mytilus galloprovincialis)
by: J. Giannessi, et al.
Published: (2024-11-01)

Ultrasensitive Lateral Flow Immunoassay of Fluoroquinolone Antibiotic Gatifloxacin Using Au@Ag Nanoparticles as a Signal-Enhancing Label
by: Olga D. Hendrickson, et al.
Published: (2024-12-01)

Complexation of fluoroquinolones with magnesium ions
by: V. M. Bakhtin, et al.
Published: (2022-10-01)

Theoretically improved biodegradability of fluoroquinolones in sewage and sludge
by: Yajing Liu, et al.
Published: (2025-09-01)

Exploring fluoroquinolone resistance mechanisms and the effects of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) in Acinetobacter baumannii
by: Mohsen Nazari, et al.
Published: (2025-05-01)

Effectiveness of antimicrobial therapy for community-acquired pneumonia in real clinical practice
by: O. M. Uryasev, et al.
Published: (2022-01-01)

Seasonal Determination of Antibiotic-Resistant Microorganisms and Ciprofloxacin Residues in Pork and Chicken Meats Collected from Fresh Markets in Chiang Mai, Northern Thailand
by: Sirikwan Dokuta, et al.
Published: (2025-01-01)

Prevalence of Site-Specific Mycoplasma genitalium Infection and Macrolide and Fluoroquinolone-Associated Mutations in Men Who Have Sex with Men in Shenzhen, China
by: Leng X, et al.
Published: (2025-01-01)

Investigating long-term risk of aortic aneurysm and dissection from fluoroquinolones and the key contributing factors using machine learning methods
by: Hsiao-Wei Wang, et al.
Published: (2025-04-01)

High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
by: Julia Wicherski, et al.
Published: (2025-02-01)

Fluoroquinolones and glucocorticoids as risk factors for cranial cruciate ligament disease in Retrievers
by: Jessica Bunch, et al.
Published: (2025-07-01)

Changes in the Eradication Efficacy of Fluoroquinolone-containing Triple Therapy for Infection in Korea
by: Jung Won Lee, et al.
Published: (2020-06-01)

Cytologic status changes of the conjunctiva and tears qualitative composition in patients with «dry eye» syndrome after instillation of modern topical fluoroquinolones
by: N. G. Zavgorodnyaya, et al.
Published: (2014-06-01)

Nalidixic acid—a good marker of fluoroquinolone resistance mechanisms in Escherichia coli
by: Sofia Kalinen, et al.
Published: (2025-07-01)

Fluoroquinolones for the Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis: Are They Losing Ground?
by: Simona Juncu, et al.
Published: (2025-04-01)

New Aspects of the Antibiotics Use in Ophthalmology: the View of a Clinical Pharmacologist
by: G. Yu. Knorring
Published: (2024-10-01)

Enhanced Biofilm Disruption in Methicillin-Resistant <i>Staphylococcus aureus</i> Using Rifampin and Fluoroquinolone Combinations
by: Yu Ri Kang, et al.
Published: (2025-04-01)

Association between virulence profile and fluoroquinolone resistance in Escherichia coli isolated from dogs and cats in China
by: Xiaoqiang Liu, et al.
Published: (2017-04-01)

Efficacy and Tolerance of Rezonizate in Complex with Fluoroquinolones or Mycobutin on a Model of Experimental Murine Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01)

Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams
by: Samuel Kariuki, et al.
Published: (2007-12-01)

Bjerkandera adusta TM11 for the bioremediation of fluoroquinolone antibiotics spiked in wastewater: A sustainable approach to pharmaceutical contaminant biotransformation
by: Hasna Befenzi, et al.
Published: (2025-02-01)

In-vitro Antibacterial Evaluation of Some Fluoroquinolone Derivatives Against Food Borne Bacteria
by: N. Shariatifar, et al.
Published: (2016-04-01)